KR102240357B1 - Antioxidant composition for cosmetics containing a compound isolated from extract of Rosa rugosa Thumb - Google Patents

Antioxidant composition for cosmetics containing a compound isolated from extract of Rosa rugosa Thumb Download PDF

Info

Publication number
KR102240357B1
KR102240357B1 KR1020180172779A KR20180172779A KR102240357B1 KR 102240357 B1 KR102240357 B1 KR 102240357B1 KR 1020180172779 A KR1020180172779 A KR 1020180172779A KR 20180172779 A KR20180172779 A KR 20180172779A KR 102240357 B1 KR102240357 B1 KR 102240357B1
Authority
KR
South Korea
Prior art keywords
extract
compound
formula
isolated
compounds
Prior art date
Application number
KR1020180172779A
Other languages
Korean (ko)
Other versions
KR20200082315A (en
Inventor
이성진
이광형
민동수
김수환
김건우
배은영
Original Assignee
주식회사 차메디텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 차메디텍 filed Critical 주식회사 차메디텍
Priority to KR1020180172779A priority Critical patent/KR102240357B1/en
Publication of KR20200082315A publication Critical patent/KR20200082315A/en
Application granted granted Critical
Publication of KR102240357B1 publication Critical patent/KR102240357B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738Rosa (rose)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 매괴화 추출물로부터 분리한 화학식 1 내지 6의 화합물로 이루어진 군으로부터 선택되는 1 종 이상의 화합물을 유효성분으로 함유하는 것을 특징으로 하는 화장품용 항산화 조성물에 관한 것이다.
상기 매괴화 추출물로부터 분리한 화합물을 유효성분으로 함유하는 화장품용 항산화 조성물은 매괴화 추출물의 에틸아세테이트 분획물로부터 효율적으로 화합물 1 내지 6을 분리하여 항산화 성분을 갖는 화장품의 조성물로 유용하게 사용될 수 있는 효과가 있다.
The present invention relates to an antioxidant composition for cosmetics, characterized in that it contains as an active ingredient at least one compound selected from the group consisting of compounds of Formulas 1 to 6 isolated from the maemaehwa extract.
Antioxidant composition for cosmetics containing the compound isolated from the maemaebu extract as an active ingredient effectively separates the compounds 1 to 6 from the ethyl acetate fraction of the maebubu extract and can be usefully used as a cosmetic composition having an antioxidant component. There is.

Figure 112018131963130-pat00018
Figure 112018131963130-pat00018

Description

매괴화 추출물로부터 분리한 화합물을 유효성분으로 함유하는 화장품용 항산화 조성물{Antioxidant composition for cosmetics containing a compound isolated from extract of Rosa rugosa Thumb} Antioxidant composition for cosmetics containing a compound isolated from extract of Rosa rugosa Thumb}

본 발명은 매괴화 추출물로부터 분리한 화합물을 유효성분으로 함유하는 화장품용 항산화 조성물에 관한 것으로, 더 상세하게는 매괴화를 용매로 추출한 후 분획용매로써 물과 에틸아세테이트를 각각 사용하여 분획한 분획추출물을 분리한 화합물을 유효성분으로 함유한 항산화 효과가 우수한 조성물에 관한 것이다. The present invention relates to a cosmetic antioxidant composition containing as an active ingredient a compound isolated from a maebu extract, and more particularly, a fractionated extract obtained by extracting maebu with a solvent and then using water and ethyl acetate as fractionation solvents, respectively. It relates to a composition having an excellent antioxidant effect containing a compound separated by as an active ingredient.

매괴화는 장미과에 속한 해당화의 꽃봉오리를 말한다. 해당화는 주로 바닷가 모래땅이나 산기슭에 자생하는 낙엽활엽관목으로, 잎은 어긋나며 작은 잎은 타원형 또는 도란형으로 밑이 날카롭고 끝은 뭉뚝하거나 또는 둥글며 톱니가 있고 뒷면에 선점과 융모가 있다. 꽃은 붉은색으로 5월에 피고, 과실은 가장과로 거의 구형이며 황적색으로 8월에 익는다. 해당화의 화학적 성분으로 β-sitosterol, campesterol, euscaphic acid, β-sitosteryl-β-D-glucopyanoside, campesteryl-β-D-glucopyranoside, rosamultin, arjunetin, (+)-catechin 등이 알려져있다. Plum blossom refers to the flower buds of the flower belonging to the Rosaceae family. This flower is a deciduous broad-leaved shrub that grows naturally in the sandy area of the beach or at the foot of the mountain. The leaves are dislocated, the small leaves are oval or obovate, the bottom is sharp, the ends are blunt or round, serrated, and there are preoccupants and villi on the back side. The flower is red and blooms in May, and the fruit is the most globular, yellow-red, and ripens in August. Chemical components of glycosylation include β-sitosterol, campesterol, euscaphic acid, β-sitosteryl-β-D-glucopyanoside, campesteryl-β-D-glucopyranoside, rosamultin, arjunetin, and (+)-catechin.

매괴화는 비(脾), 간(肝)의 이경(二經)에 들어가서 혈(血)을 통하게 하고, 기(氣)를 이롭게 하며, 풍비(風)를 치료하는 약물이다. 행혈(行血), 조경(調經), 항염증약으로서 위통(胃痛), 유옹종통(乳癰腫痛), 월경불조(月 經不調), 류마티스, 타박상(打撲傷) 등에 사용한다.Maedanghwa is a drug that enters the nose of the nose and liver, allows blood to pass through, benefits Gi, and cures wind. As an anti-inflammatory drug, it is used for blood circulation, landscaping, stomach pain, Yuongjongtong, menstrual discomfort, rheumatism, and bruises.

근래에는 매괴화 추출물 및 분획물의 항산화 활성을 인정받았지만, 특정 화합물의 항산화 활성에 대해서는 보고된 바가 없다. In recent years, the antioxidant activity of the extracts and fractions of barberry has been recognized, but there has been no report on the antioxidant activity of specific compounds.

KR 10-2013-0065185 A (2013. 06. 19.)KR 10-2013-0065185 A (2013. 06. 19.) KR 10-1825179 B1 (2018. 01. 29.)KR 10-1825179 B1 (2018.01.29.)

본 발명은 상기 종래기술이 갖는 문제점을 해결하기 위해서 안출된 것으로서, 본 발명에서 해결하고자 하는 과제는 매괴화 추출물로부터 분리된 화합물을 유효성분으로 함유하는 화장품용 항산화 조성물을 제공하는데 그 목적이 있다.The present invention has been conceived to solve the problems of the prior art, and an object to be solved in the present invention is to provide an antioxidant composition for cosmetics containing a compound isolated from a maebustion extract as an active ingredient.

또한, 매괴화 추출물로부터 화학식 1 내지 6으로 표시되는 화합물을 분리하는 제조방법을 제공하는데 그 목적이 있다.In addition, it is an object of the present invention to provide a method for separating the compounds represented by Chemical Formulas 1 to 6 from the extract of maebustion.

상기와 같은 목적을 달성하기 위한 본 발명에 따른 매괴화 추출물로부터 분리한 화합물을 유효성분으로 함유하는 화장품용 항산화 조성물은 매괴화 추출물로부터 분리한 화학식 1 내지 6의 화합물로 이루어진 군으로부터 선택되는 1 종 이상의 화합물을 유효성분으로 함유하는 것을 특징으로 한다.Cosmetic antioxidant composition containing as an active ingredient the compound isolated from the maebustion extract according to the present invention for achieving the above object is one selected from the group consisting of the compounds of Formulas 1 to 6 isolated from the maebustion extract It is characterized by containing the above compound as an active ingredient.

또, 상기 매괴화 추출물의 추출용매는 물, 알코올 또는 이들의 혼합물인 것을 특징으로 한다. In addition, the extraction solvent of the plume extract is characterized in that water, alcohol, or a mixture thereof.

또, 상기 매괴화 추출물로부터 분리한 화학식 1 내지 6의 화합물은 매괴화 추출물의 에틸아세테이트 분획물로부터 분리된 것을 특징으로 한다.In addition, the compounds of Formulas 1 to 6 isolated from the maebu hwa extract is characterized in that it is isolated from the ethyl acetate fraction of the maebu hwa extract.

또, 상기 매괴화 추출물로부터 분리한 화학식 1 내지 6의 화합물은 컬럼 크로마토그래피, 고성능액체 크로마토그래피, 이온교환 크로마토그래피, 친화성 크로마토그래피 및 크기배제 크로마토그래피로 이루어진 군으로부터 선택되는 1 종 이상을 사용하여 분리하는 것을 특징으로 한다.In addition, the compounds of Formulas 1 to 6 isolated from the lumped extract used at least one selected from the group consisting of column chromatography, high performance liquid chromatography, ion exchange chromatography, affinity chromatography, and size exclusion chromatography. It is characterized by separating.

또, 상기 매괴화 추출물의 에틸아세테이트 분획물로터 분리된 화합물을 0.1~10중량%를 유효성분으로 포함하는 것을 특징으로 한다.In addition, it is characterized in that it comprises 0.1 to 10% by weight of the separated compound as an active ingredient from the ethyl acetate fraction of the lumped extract.

본 발명에 따른 매괴화 추출물로부터 분리한 화합물을 유효성분으로 함유하는 화장품용 항산화 조성물은 매괴화 추출물의 에틸아세테이트 분획물로부터 효율적으로 화합물 1 내지 6을 분리하여 항산화 성분을 갖는 화장품의 조성물로 유용하게 사용될 수 있는 효과가 있다.Cosmetic antioxidant composition containing as an active ingredient the compound isolated from the maebustion extract according to the present invention is effectively used as a cosmetic composition having an antioxidant component by separating compounds 1 to 6 from the ethylacetate fraction of the maebustion extract efficiently. There is an effect that can be.

도 1은 본 발명에 따른 매괴화로부터 분리한 화합물 1 내지 6의 분리과정을 나타낸 도면이다.
도 2는 본 발명에 따른 매괴화 추출물의 에틸아세테이트 분획물의 DPPH 활성을 나타낸 도면이다.
도 3은 본 발명에 따른 50% 메탄올 분획물의 DPPH 활성을 나타낸 도면이다.
도 4는 본 발명에 따른 50% 메탄올 분획물에서 분리된 6개의 화합물에 대한 DPPH 활성을 나타낸 것이다.
도 5는 본 발명에 따른 매괴화 추출물에서 분리된 6개의 화합물의 UPLC를 분석한 결과를 나타낸 도면이다.
도 6은 본 발명에 따른 매괴화 추출물에서 분리된 6개의 화합물의 자외선 스펙트럼을 나타낸 도면이다.
도 7은 본 발명에 따른 매괴화 추출물에서 분리된 6개의 화합물의 UPLC-HR-ESI-MS 스펙트럼을 나타낸 도면이다.
도 8은 본 발명에 따른 매괴화 추출물에서 분리된 6개의 화합물 중 화합물 1의 1H NMR 스펙트럼을 나타낸 도면이다.
도 8은 본 발명에 따른 매괴화 추출물에서 분리된 6개의 화합물 중 화합물 1의 1H NMR 스펙트럼을 나타낸 도면이다.
도 9는 본 발명에 따른 매괴화 추출물에서 분리된 6개의 화합물 중 화합물 2의 1H NMR 스펙트럼을 나타낸 도면이다.
도 10은 본 발명에 따른 매괴화 추출물에서 분리된 6개의 화합물 중 화합물 3 1H NMR 스펙트럼을 나타낸 도면이다.
도 11은 본 발명에 따른 매괴화 추출물에서 분리된 6개의 화합물 중 화합물 5의 1H NMR 스펙트럼을 나타낸 도면이다.
도 12는 본 발명에 따른 매괴화 추출물에서 분리된 6개의 화합물 중 화합물 6의 1H NMR 스펙트럼을 나타낸 도면이다.
1 is a view showing the separation process of compounds 1 to 6 separated from the mass formation according to the present invention.
Figure 2 is a diagram showing the DPPH activity of the ethyl acetate fraction of the maekkaethwa extract according to the present invention.
Figure 3 is a diagram showing the DPPH activity of the 50% methanol fraction according to the present invention.
Figure 4 shows the DPPH activity for the six compounds isolated from the 50% methanol fraction according to the present invention.
Figure 5 is a view showing the results of UPLC analysis of the six compounds isolated from the extract according to the present invention.
Figure 6 is a view showing the ultraviolet spectrum of the six compounds isolated from the extract according to the present invention.
7 is a view showing the UPLC-HR-ESI-MS spectrum of the six compounds isolated from the extract according to the present invention.
Figure 8 is a diagram showing the 1H NMR spectrum of Compound 1 of the six compounds isolated from the extract according to the present invention.
Figure 8 is a diagram showing the 1H NMR spectrum of Compound 1 of the six compounds isolated from the extract according to the present invention.
9 is a view showing the 1H NMR spectrum of Compound 2 of the six compounds isolated from the extract according to the present invention.
FIG. 10 is a diagram showing a 1H NMR spectrum of Compound 3 among 6 compounds isolated from the extract of maegaehwa according to the present invention.
11 is a diagram showing the 1H NMR spectrum of compound 5 among the six compounds isolated from the maemaehwa extract according to the present invention.
12 is a diagram showing the 1H NMR spectrum of compound 6 among the six compounds isolated from the maemaehwa extract according to the present invention.

본 발명은 매괴화 추출물로부터 분리한 화학식 1 내지 6의 화합물로 이루어진 군으로부터 선택되는 1 종 이상의 화합물을 유효성분으로 함유하는 화장품용 항산화 조성물에 관한 것이다.The present invention relates to an antioxidant composition for cosmetics containing as an active ingredient at least one compound selected from the group consisting of compounds of Formulas 1 to 6 isolated from the extract of maegaehwa.

[화학식 1][Formula 1]

Figure 112018131963130-pat00001
Figure 112018131963130-pat00001

화학식 1로 표시되는 화합물 1은 Rutin으로 지칭될 수 있다. Compound 1 represented by Formula 1 may be referred to as Rutin.

MW(분자량) : 610.51 MW (molecular weight): 610.51

Molecular Formula(분자식) : C27H30O16 Molecular Formula: C 27 H 30 O 16

[화학식 2][Formula 2]

Figure 112018131963130-pat00002
Figure 112018131963130-pat00002

화학식 2로 표시되는 화합물 2는 Hyperoside로 지칭될 수 있다.Compound 2 represented by Formula 2 may be referred to as Hyperoside.

MW(분자량) : 464.37 MW (molecular weight): 464.37

Molecular Formula(분자식) : C21H20O12 Molecular Formula: C 21 H 20 O 12

[화학식 3][Formula 3]

Figure 112018131963130-pat00003
Figure 112018131963130-pat00003

화학식 3으로 표시되는 화합물 3은 Isoquercitrin으로 지칭될 수 있다.Compound 3 represented by Chemical Formula 3 may be referred to as Isoquercitrin.

MW(분자량) : 464.09 MW (molecular weight): 464.09

Molecular Formula(분자식) : C21H20O12 Molecular Formula: C 21 H 20 O 12

[화학식 4][Formula 4]

Figure 112020066051622-pat00030
Figure 112020066051622-pat00030

화학식 4로 표시되는 화합물 4는 Hyperin 6''-gallate로 지칭될 수 있다. Compound 4 represented by Chemical Formula 4 may be referred to as Hyperin 6''-gallate.

MW(분자량) : 616.48 MW (molecular weight): 616.48

Molecular Formula(분자식) : C28H24O16 Molecular Formula: C 28 H 24 O 16

[화학식 5][Formula 5]

Figure 112018131963130-pat00005
Figure 112018131963130-pat00005

화학식 5로 표시되는 화합물 5는 Avicularin로 지칭될 수 있다. Compound 5 represented by Chemical Formula 5 may be referred to as Avicularin.

MW(분자량) : 434.08 MW (molecular weight): 434.08

Molecular Formula(분자식) : C20H18O11 Molecular Formula: C 20 H 18 O 11

[화학식 6][Formula 6]

Figure 112021022417104-pat00034
Figure 112021022417104-pat00034

화학식 6으로 표시되는 화합물 6은 2-Phenylethyl 6-O-galloyl-β-D-glucopyranoside로 지칭될 수 있다.Compound 6 represented by Chemical Formula 6 may be referred to as 2-Phenylethyl 6-O-galloyl-β-D-glucopyranoside.

MW(분자량) : 436.14MW (molecular weight): 436.14

Molecular Formula(분자식) : C21H24O10 Molecular Formula: C 21 H 24 O 10

상기 매괴화 추출물로부터 분리한 화학식 1 내지 6의 화합물은 매괴화 추출물의 에틸아세테이트 분획물로부터 분리한 것이며, 상기 매괴화 추출물로부터 분리한 화합물은 5개의 플라보노이드 화합물과 1개의 페놀 화합물이다.The compounds of Formulas 1 to 6 isolated from the maebu hwa extract are isolated from the ethyl acetate fraction of the maebu hwa extract, and the compounds isolated from the maebu hwa extract are five flavonoid compounds and one phenolic compound.

먼저, 상기 매괴화 추출물은 친수성 용매로 추출된 것이며, 상기 친수성 용매는 물, 알코올 또는 이들의 혼합물일 수 있다. 상기 알코올은 에탄올, 메탄올, n-프로판올, 이소프로판올, n-부탄올, sec-부탄올, 이소부탄올, tert-부탄올 또는 이들의 혼합물일 수 있으나 이에 제한되지 않는다. 본 발명에서는 상기 매괴화 추출물의 추출용매로 100% 에탄올을 사용하여 추출한다.First, the lumping extract is extracted with a hydrophilic solvent, and the hydrophilic solvent may be water, alcohol, or a mixture thereof. The alcohol may be ethanol, methanol, n-propanol, isopropanol, n-butanol, sec-butanol, isobutanol, tert-butanol, or a mixture thereof, but is not limited thereto. In the present invention, the extract is extracted using 100% ethanol as an extraction solvent for the lumping extract.

그리고, 매괴화 추출물을 분획 용매를 사용하여 분획물을 제조함에 있어서, 본 발명에서는 에틸아세테이트를 이용하여 분획물을 제조하였다.In addition, in preparing a fraction using a fractionation solvent for the lumped extract, in the present invention, a fraction was prepared using ethyl acetate.

또한, 상기 매괴화 추출물의 에틸아세테이트 분획물로터 분리된 화합물은 크로마토그래피 또는 여과일 수 있으며, 상기 크로마토그래피는 컬럼 크로마토그래피, 고성능액체 크로마토그래피(HPLC), 이온교환 크로마토그래피, 친화성 크로마토그래피 및 크기배제 크로마토그래피 또는 그 조합일 수 있다.In addition, the compound separated from the ethyl acetate fraction of the massif extract may be chromatography or filtration, and the chromatography may be column chromatography, high performance liquid chromatography (HPLC), ion exchange chromatography, affinity chromatography, and size. It may be exclusion chromatography or a combination thereof.

상기 매괴화 추출물의 에틸아세테이트 분획물로부터 분리된 화합물은 항산화 성분을 갖는 화장품의 조성물로 사용될 수 있다.The compound isolated from the ethylacetate fraction of the maegaehwa extract can be used as a cosmetic composition having an antioxidant component.

또한, 전체 조성물에 대하여, 매괴화 추출물의 에틸아세테이트 분획물로부터 분리된 화합물을 0.1~10중량%를 유효성분으로 포함하는 것이 바람직하다.In addition, with respect to the total composition, it is preferable to include 0.1 to 10% by weight of the compound isolated from the ethylacetate fraction of the maebustion extract as an active ingredient.

이는 최소한의 항산화 성분 효과를 달성할 수 있도록 조성물의 함량은 상기 최소치 이상인 것이 바람직하며, 과량 첨가에 따른 사용감 저하 및 각종 제형에의 적용가능성을 고려하여 조성물의 함량은 상기 최대치 이하인 것이 바람직하다.It is preferable that the content of the composition is more than the minimum value so as to achieve the minimum antioxidant effect, and the content of the composition is preferably less than the maximum value in consideration of the reduction in feeling of use and applicability to various formulations due to excessive addition.

이하에서 실시예를 통하여 본 발명을 더욱 구체적으로 설명한다. 그러나 하 기의 실시예는 본 발명을 구체적으로 예시하기 위한 것일 뿐, 본 발명의 권리범위를 제한하는 것이 아님은 통상의 기술자에게 있어서 명백한 사실이다. 즉, 본 발명의 단순한 변형 내지 변경은 통상의 기술자에 의하여 용이하게 실시될 수 있으며, 이러한 변형이나 변경은 모두 본 발명의 영역에 포함되는 것으로 볼 수 있다.Hereinafter, the present invention will be described in more detail through examples. However, the following examples are for illustrative purposes only, and are not intended to limit the scope of the present invention, which is obvious to those skilled in the art. That is, simple modifications or changes of the present invention can be easily implemented by a person skilled in the art, and all such modifications or changes can be considered to be included in the scope of the present invention.

실시예 1 : 매괴화 추출물, 분획물 제조 및 분획물로부터 화합물 분리Example 1: Preparation of the extract, fraction and separation of the compound from the fraction

도 1은 매괴화로부터 분리한 화합물 1 내지 6의 분리과정을 나타낸 도면이다.1 is a diagram showing the separation process of compounds 1 to 6 separated from buried formation.

도 1을 참조하여 매괴화 추출물, 분획물 제조 및 분획물로부터 화합물 분리 방법을 설명하면, 매괴화 1kg을 50℃에서 100% 에탄올 3L로 추출하였다. 상기 추출한 매괴회추출물 70g을 물 2L에 현탁시키고 에틸아세테이트로 분획시켰다. 에틸아세테이트 분획을 감압하에 증발시켜 26g의 갈색 잔류물을 수득하였다. 용매 분획을 DPPH- 소거 활성에 대해 시험하였다. 이 중 에틸아세테이트 분획은 항산화제 활성을 나타냈다.Referring to Figure 1 to describe the method of separating the compound from the fractions and the extract, the fraction and the fractions, 1 kg of the cultivation was extracted with 3L of 100% ethanol at 50°C. 70 g of the extracted barberry ash extract was suspended in 2 L of water and fractionated with ethyl acetate. The ethyl acetate fraction was evaporated under reduced pressure to give 26 g of a brown residue. The solvent fraction was tested for DPPH- scavenging activity. Among them, the ethyl acetate fraction showed antioxidant activity.

상기 분획된 분획물 26g을 메탄올과 물(0:100, 30:70, 50:50, 70:30 및 100:0)을 사용하여 단계 구배 용출로 역상 컬럼 크로마토 그래피(YMC- 겔 RP-C18, 70-230 메쉬, 500g) 각 500mL로 용리시켜 5개의 분획물(Fr.1 내지 5)을 수득하였다. 다시 Fr. 3(12.8g)을 추가로 메탄올-물(단계별로 20:80 내지 100:0 ; 500mL)의 단계적 구배를 사용하여 RP 컬럼 크로마토 그래피로 정제하여 12개의 분획물(Fr.3-1 내지 Fr.3-12)을 HPLC(YMC-Pack ODS-A, 5㎛, φ20 × 150mm, UV 254nm, 유속 2㎖/분)에 의해 3-6(1.1g)을 순차적으로 분리하고, 화합물 1(16.5mg), 화합물 2(21.4mg), 화합물 3(48.1mg), 화합물 4(4mg),화합물 5(6.3mg) 및 화합물 6(40.7mg)을 수득하였다.26 g of the fractionated fraction was subjected to reverse phase column chromatography (YMC-gel RP-C18, 70) by step gradient elution using methanol and water (0:100, 30:70, 50:50, 70:30 and 100:0). -230 mesh, 500g) was eluted with each 500mL to obtain 5 fractions (Fr. 1 to 5). Again Fr. 3 (12.8 g) was further purified by RP column chromatography using a stepwise gradient of methanol-water (step by step 20:80 to 100:0; 500 mL) to obtain 12 fractions (Fr.3-1 to Fr.3). -12) 3-6 (1.1g) was sequentially separated by HPLC (YMC-Pack ODS-A, 5㎛, φ20 × 150mm, UV 254nm, flow rate 2ml/min), and Compound 1 (16.5mg) , Compound 2 (21.4 mg), Compound 3 (48.1 mg), Compound 4 (4 mg), Compound 5 (6.3 mg) and Compound 6 (40.7 mg) were obtained.

도 2는 매괴화 추출물의 에틸아세테이트 분획물과 분획의 DPPH 활성을 나타낸 것이며, 도 3은 50% 메탄올 분획의 DPPH 활성을 나타낸 것이며, 도 4는 50% 메탄올 분획물에서 분리된 6개의 화합물에 대한 DPPH 활성을 나타낸 것이다.Figure 2 shows the DPPH activity of the ethyl acetate fraction and the fraction of the maehwa extract, Figure 3 shows the DPPH activity of the 50% methanol fraction, Figure 4 is the DPPH activity for the six compounds isolated from the 50% methanol fraction Is shown.

실험예 1 : 매괴화 추출물에서 분리된 6개의 화합물 분석Experimental Example 1: Analysis of 6 compounds isolated from the extract of maebustion

(1) UPLC/MS 분석(1) UPLC/MS analysis

매괴화 추출물에서 분리된 6개의 화합물을 UPLC/Q-TOF MS로 분석하였다.The six compounds isolated from the maehwa extract were analyzed by UPLC/Q-TOF MS.

UPLC/MS 분석은 Waters SYNAPT G2-Si 고화질 질량 분광기와 결합된 Waters ACQUITY UPLC시스템에서 수행되었다. 크로마토그래피 분리는 35℃에서 ACQUITY UPLC HSS C18(100mm × 2.1mm, 1.8μm) 컬럼을 사용하고, 10℃의 자동 샘플러 온도에서 수행하였다. 이동상 A는 물로 구성되고, 이동상 B는 아세토니트릴로 구성된다. 용매는 초기에 20% B로부터 0.3mL/min의 유속에서 50분에 걸쳐 20~30% B로 변화한다(표 1). 이어서 다음 샘플 주입 전에 95% B를 사용하여 15분 동안 세척하였다. UV 검출기를 사용하여 254nm에서 크로마토 그램을 모니터링했다.UPLC/MS analysis was performed on a Waters ACQUITY UPLC system combined with a Waters SYNAPT G2-Si high-definition mass spectrometer. Chromatographic separation was performed at 35° C. using an ACQUITY UPLC HSS C18 (100 mm×2.1 mm, 1.8 μm) column, and at 10° C. auto sampler temperature. Mobile phase A consists of water and mobile phase B consists of acetonitrile. The solvent initially changes from 20% B to 20-30% B over 50 minutes at a flow rate of 0.3 mL/min (Table 1). It was then washed for 15 minutes with 95% B before the next sample injection. The chromatogram was monitored at 254 nm using a UV detector.

UPLC-HR-MS 분석을 위해, 음이온 전기 분무 모드에서 모세관 전압 및 원추 전압을 2.0kV로 설정하였다.For UPLC-HR-MS analysis, capillary voltage and cone voltage were set to 2.0 kV in negative ion electrospray mode.

질량 분석은 20nL/min의 유속에서 leukine enkephalin (Sigma Aldrich) 300 ng/mL 용액으로 구성된 외부 기준(Lock-Spray)을 사용하여 획득 중에 보정하였고, 정확성과 재현성을 보장하기 위해 음이온 모드([M-H] - m / z = 554.2615)로 기준 이온을 생성하였다. 그 결과는 도 5에 나타내었다.Mass spectrometry was calibrated during acquisition using an external reference (Lock-Spray) consisting of 300 ng/mL solution of leukine enkephalin (Sigma Aldrich) at a flow rate of 20 nL/min, and negative ion mode ([MH]) to ensure accuracy and reproducibility. -m / z = 554.2615) to generate a reference ion. The results are shown in FIG. 5.

Figure 112018131963130-pat00007
Figure 112018131963130-pat00007

(2) HPLC-PDA 분석(2) HPLC-PDA analysis

HPLC 분석은 Shimadzu-HPLC 시스템 (Shimadzu Corporation, Kyoto, Japan)에서 수행되었으며, CBM-20A 제어기, LC-20AP 펌프 및 SPD-M20A 포토 다이오드 어레이(PDA) 검출기가 포함된다. 크로마토그래피 분리는 Luna C18 역상 컬럼(250㎜ × 4.6㎜, 5㎛)상에서 달성되었다. 분석 조건은 아래 표 2와 같다.HPLC analysis was performed on a Shimadzu-HPLC system (Shimadzu Corporation, Kyoto, Japan) and included a CBM-20A controller, LC-20AP pump and SPD-M20A photodiode array (PDA) detector. Chromatographic separation was achieved on a Luna C18 reverse phase column (250 mm x 4.6 mm, 5 μm). Analysis conditions are shown in Table 2 below.

Figure 112018131963130-pat00008
Figure 112018131963130-pat00008

(3) DPPH 라디칼 소거능 측정(3) DPPH radical scavenging ability measurement

DPPH(1,1-diphenyl-2-picrylhydrazyl) 분석은 항산화활성 측정 방법 중 가장 널리 이용되는 방법이며, 모든 실험은 3번 수행되었다. Ascorbic acid를 양성 대조군으로 사용하였고, 항산화 활성 프로파일은 DPPH (1,1-diphenyl-2picrylhydrazyl)를 사용하여 각 분획의 라디칼 소거능을 측정함으로써 생성되었다. 각 분획을 진공 농축기를 사용하여 원심 분리기로 건조시키고 메탄올에서 재구성하여 10mg/mL 저장 용액을 만들었다. 22 개의 모든 원액을 메탄올로 희석하고 150μM DPPH 수용액 190μL와 혼합하였다.DPPH (1,1-diphenyl-2-picrylhydrazyl) analysis is the most widely used method of measuring antioxidant activity, and all experiments were performed three times. Ascorbic acid was used as a positive control, and the antioxidant activity profile was generated by measuring the radical scavenging ability of each fraction using DPPH (1,1-diphenyl-2picrylhydrazyl). Each fraction was dried with a centrifuge using a vacuum concentrator and reconstituted in methanol to make a 10 mg/mL stock solution. All 22 stock solutions were diluted with methanol and mixed with 190 μL of 150 μM DPPH aqueous solution.

나머지 DPPH의 흡광도는 20 분후 517 nm에서 다음과 같이 측정되었다.The absorbance of the remaining DPPH was measured at 517 nm after 20 minutes as follows.

Abt = 시험된 추출물을 사용한 DPPH 용액의 흡광도Ab t = absorbance of DPPH solution using the tested extract

Ab0 = 에탄올 첨가시 DPPH 용액의 흡광도Ab 0 = absorbance of DPPH solution upon addition of ethanol

Abb = 메탄올을 첨가하여 시험한 추출 용액의 흡광도.Ab b = absorbance of the extraction solution tested by adding methanol.

Figure 112018131963130-pat00009
Figure 112018131963130-pat00009

(4) 결과(4) result

UV 스펙트럼을 각 화합물 6개와 본 발명의 매괴화 추출물에서 분리된 6개의 화합물과 비교하여 6가지 화합물은 5개의 플라보노이드 화합물과 하나의 페놀 화합물로 확인했다. 화합물의 구조는 HR-ESI-MS, NMR 및 문헌에서의 NMR 분석에 의해 확립되었다. 그 결과는 도 6에 나타내었다.The UV spectra were compared with each of the 6 compounds and the 6 compounds isolated from the cultivated extract of the present invention, and the 6 compounds were identified as 5 flavonoid compounds and one phenolic compound. The structure of the compound was established by HR-ESI-MS, NMR and NMR analysis in the literature. The results are shown in FIG. 6.

또한, 본 발명의 매괴화 추출물에서 분리된 6개의 화합물은 NMR 분석에 의해 그 구조는 화학적 증거, 물리적 방법 및 문헌에서 보고된 구조와 비교하여 결정되었다. 그 결과는 도 7 및 아래 표 3, 4에 나타내었다.In addition, the structure of the six compounds isolated from the extract of the present invention was determined by NMR analysis by comparison with chemical evidence, physical methods, and structures reported in the literature. The results are shown in Fig. 7 and Tables 3 and 4 below.

Figure 112020066051622-pat00031
Figure 112020066051622-pat00031

Figure 112020066051622-pat00032
Figure 112020066051622-pat00032

표 4를 통하여 알 수 있는 바와 같이, 화합물 1 내지 6을 비교하면, (6) > (5) > (3) > (1) > (2) > (4) 순으로, 이들 화합물에 대한 자유라디컬 실험을 통한 항산화능을 확인할 수 있다. 분리정제된 6개의 화합물 중에서, 화합물 6은 항산화 효과가 제일 높게 나타났다.As can be seen from Table 4, when comparing compounds 1 to 6, in the order of (6)> (5)> (3)> (1)> (2)> (4), free radicals for these compounds You can check the antioxidant activity through the curl experiment. Among the six isolated and purified compounds, compound 6 showed the highest antioxidant effect.

Claims (5)

항산화 성분을 갖는 화장품 조성물에 있어서,
매괴화 1kg을 50℃에서 100% 에탄올 3L로 추출하고, 상기 추출한 매괴화추출물 70g을 물 2L에 현탁시키고 에틸아세테이트로 분획시킨 후, 상기 에틸아세테이트 분획물에 메탄올과 물을 중량대비 0:100, 30:70, 50:50, 70:30 및 100:0을 사용하여 역상 컬럼 크로마토그래피에 용리시켜 5개의 분획물을 수득한 후, 상기 분획물 중 메탄올과 물을 중량대비 50:50으로 분획한 분획물을 메탄올-물의 단계적 구배를 사용하여 역상 컬럼 크로마토그래피로 정제시켜 12개의 분획물을 수득하고, 다시 고성능액체 크로마토그래피를 통해 분리한 화학식 1 내지 6으로 이루어진 화합물을 유효성분으로 함유하되,
상기 매괴화 추출물의 에틸아세테이트 분획물로부터 분리된 화합물 0.1~10중량%를 유효성분으로 포함하는 것을 특징으로 하는 화장품용 항산화 조성물.

[화학식 1]
Figure 112021022417104-pat00012

[화학식 2]
Figure 112021022417104-pat00013

[화학식 3]
Figure 112021022417104-pat00014

[화학식 4]
Figure 112021022417104-pat00033

[화학식 5]
Figure 112021022417104-pat00016

[화학식 6]
Figure 112021022417104-pat00035

In the cosmetic composition having an antioxidant component,
1 kg of crushed mass was extracted with 3L of 100% ethanol at 50°C, and 70 g of the extracted mass lumped extract was suspended in 2L of water and fractionated with ethyl acetate, and methanol and water were added to the ethyl acetate fraction by weight of 0:100, 30 :70, 50:50, 70:30, and 100:0 were eluted by reverse-phase column chromatography to obtain 5 fractions, and the fraction obtained by dividing methanol and water at a weight ratio of 50:50 among the fractions was methanol. -Twelve fractions were obtained by purification by reverse phase column chromatography using a stepwise gradient of water, and a compound consisting of Formulas 1 to 6 separated through high performance liquid chromatography was contained as an active ingredient,
Cosmetic antioxidant composition comprising 0.1 to 10% by weight of the compound isolated from the ethyl acetate fraction of the maebustion extract as an active ingredient.

[Formula 1]
Figure 112021022417104-pat00012

[Formula 2]
Figure 112021022417104-pat00013

[Formula 3]
Figure 112021022417104-pat00014

[Formula 4]
Figure 112021022417104-pat00033

[Formula 5]
Figure 112021022417104-pat00016

[Formula 6]
Figure 112021022417104-pat00035

삭제delete 삭제delete 삭제delete 삭제delete
KR1020180172779A 2018-12-28 2018-12-28 Antioxidant composition for cosmetics containing a compound isolated from extract of Rosa rugosa Thumb KR102240357B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180172779A KR102240357B1 (en) 2018-12-28 2018-12-28 Antioxidant composition for cosmetics containing a compound isolated from extract of Rosa rugosa Thumb

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180172779A KR102240357B1 (en) 2018-12-28 2018-12-28 Antioxidant composition for cosmetics containing a compound isolated from extract of Rosa rugosa Thumb

Publications (2)

Publication Number Publication Date
KR20200082315A KR20200082315A (en) 2020-07-08
KR102240357B1 true KR102240357B1 (en) 2021-04-14

Family

ID=71600351

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180172779A KR102240357B1 (en) 2018-12-28 2018-12-28 Antioxidant composition for cosmetics containing a compound isolated from extract of Rosa rugosa Thumb

Country Status (1)

Country Link
KR (1) KR102240357B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102617783B1 (en) * 2021-02-17 2023-12-22 원광대학교산학협력단 Cosmetic composition for suppressing aging comprising Rosa rugosa flower extract and rosamultin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100262296B1 (en) * 1997-10-25 2000-08-01 박호군 Use of β-glucogallin as anti-oxidation agent and isolation process of β-glucogallin
KR20130065185A (en) 2011-12-09 2013-06-19 대구한의대학교산학협력단 A natural food additive comprising an extract of rosa rugosa as an active ingredient, and the preparation thereof
EP3326638A4 (en) 2015-07-17 2019-01-09 Korea Research Institute of Bioscience and Biotechnology Pharmaceutical composition for preventing or treating il-6-mediated diseases comprisingrosa rugosa

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Determination of the volatile and polyphenol constituents and the antimicrobial, antioxidant, and tyrosinase inhibitory activities of the bioactive compounds from the by-product of Rosa rugosa Thunb. var. plena Regal tea, BMC Complementary Medicine and Therapies,18, 307(2018.11.20.) 1부.*
Evaluation of rose roots, a post-harvest plantation residue as a source of phytochemicals with radical scavenging, cytotoxic, and antimicrobial activity, Industrial Crops and Products, 69, 129-136(2015.02.20.) 1부.*
South African Journal of Botany, 91, pp.37-42(2013.12.22.)

Also Published As

Publication number Publication date
KR20200082315A (en) 2020-07-08

Similar Documents

Publication Publication Date Title
Dai et al. Preparative isolation and purification of seven main antioxidants from Eucommia ulmoides Oliv.(Du-zhong) leaves using HSCCC guided by DPPH-HPLC experiment
Oniszczuk et al. Extraction methods for the determination of phenolic compounds from Equisetum arvense L. herb
Gouveia et al. Artemisia annua L.: Essential oil and acetone extract composition and antioxidant capacity
Maietti et al. Metabolite profiling of flavonols and in vitro antioxidant activity of young shoots of wild Humulus lupulus L.(hop)
Mahfoudhi et al. Metabolite profiling of polyphenols in the Tunisian plant Tamarix aphylla (L.) Karst.
Juan-Badaturuge et al. Antioxidant principles of Tanacetum vulgare L. aerial parts
Maldini et al. Phenolic compounds from Byrsonima crassifolia L. bark: Phytochemical investigation and quantitative analysis by LC-ESI MS/MS
Song et al. Determination of polyphenol components of Korean prostrate spurge (Euphorbia supina) by using liquid chromatography—tandem mass spectrometry: overall contribution to antioxidant activity
Niu et al. Main iridoid glycosides and HPLC/DAD-Q-TOF-MS/MS profile of glycosides from the antioxidant extract of Eucommia ulmoides Oliver seeds
Bhandari et al. Online HPLC-DPPH method for antioxidant activity of Picrorhiza kurroa Royle ex Benth. and characterization of kutkoside by Ultra-Performance LC-electrospray ionization quadrupole time-of-flight mass spectrometry
Veryser et al. N-alkylamide profiling of Achillea ptarmica and Achillea millefolium extracts by liquid and gas chromatography–mass spectrometry
Vijayalakshmi et al. Phytochemical screening by LC-MS analysis and invitro anti-inflammatory activity of Marselia quadrifolia plant extract
KR102240357B1 (en) Antioxidant composition for cosmetics containing a compound isolated from extract of Rosa rugosa Thumb
CN103130851B (en) A kind of method being separated preparation four kinds of pelargonin derivatives from radish skin
US8282968B2 (en) Bioactive water fraction from Gomphostemma niveum
Šavikin et al. Crataegus orientalis leaves and berries: Phenolic profiles, antioxidant and anti-inflammatory activity
Cao et al. Occurrence and biological activities of phenylpropionyl iridoids
Quan et al. Xanthone constituents of the fruits of Garcinia mangostana with anticomplement activity
KR20110048401A (en) Method for preparing the extract fortified with chalcones from by-product of Angelica keiskei juice
Fecka et al. TLC determination of tannins and flavonoids in extracts from some Erodium species using chemically modified stationary phases
Destandau et al. Centrifugal partition chromatography directly interfaced with mass spectrometry for the fast screening and fractionation of major xanthones in Garcina mangostana
Luo et al. Anti-inflammatory activity of the extracts and fractions from Erigeron multiradiatus through bioassay-guided procedures
Tirloni et al. Influence of Luehea divaricata Mart. extracts on peripheral vascular resistance and the role of nitric oxide and both Ca+ 2-sensitive and Kir6. 1 ATP-sensitive K+ channels in the vasodilatory effects of isovitexin on isolated perfused mesenteric beds
KR102176710B1 (en) A cosmetic composition comprising fractions of extracts of flower of Forsythia koreana as an active ingredient
Koca et al. Evaluation of in vivo and in vitro biological activities of different extracts of Cuscuta arvensis

Legal Events

Date Code Title Description
AMND Amendment
E601 Decision to refuse application
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant